BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36049410)

  • 1. Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
    Li Y; Lv X; Wang B; Xu Z; Wang Y; Gao S; Hou D
    Eur J Radiol; 2022 Oct; 155():110499. PubMed ID: 36049410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
    Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
    Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature.
    Li Y; Lv X; Wang B; Xu Z; Wang Y; Sun M; Hou D
    Acad Radiol; 2023 Sep; 30(9):1887-1895. PubMed ID: 36586758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisequence MRI-based radiomics signature as potential biomarkers for differentiating KRAS mutations in non-small cell lung cancer with brain metastases.
    Lv X; Li Y; Wang B; Wang Y; Xu Z; Hou D
    Eur J Radiol Open; 2024 Jun; 12():100548. PubMed ID: 38298532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
    Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
    Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma.
    Huang Z; Tu X; Yu T; Zhan Z; Lin Q; Huang X
    Clin Radiol; 2024 Feb; 79(2):e305-e316. PubMed ID: 38000953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
    Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
    Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
    Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
    Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisequence MRI-based radiomics analysis for early prediction of the risk of T790M resistance in new brain metastases.
    Lv X; Li Y; Wang B; Wang Y; Pan Y; Li C; Hou D
    Quant Imaging Med Surg; 2023 Dec; 13(12):8599-8610. PubMed ID: 38106277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer.
    Ahn SJ; Kwon H; Yang JJ; Park M; Cha YJ; Suh SH; Lee JM
    Sci Rep; 2020 Jun; 10(1):8905. PubMed ID: 32483122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
    Chen BT; Jin T; Ye N; Mambetsariev I; Daniel E; Wang T; Wong CW; Rockne RC; Colen R; Holodny AI; Sampath S; Salgia R
    Magn Reson Imaging; 2020 Jun; 69():49-56. PubMed ID: 32179095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Qu J; Zhang T; Zhang X; Zhang W; Li Y; Gong Q; Yao L; Lui S
    Clin Radiol; 2024 Apr; 79(4):e582-e591. PubMed ID: 38310058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.
    Mahajan A; B G; Wadhwa S; Agarwal U; Baid U; Talbar S; Janu AK; Patil V; Noronha V; Mummudi N; Tibdewal A; Agarwal JP; Yadav S; Kumar Kaushal R; Puranik A; Purandare N; Prabhash K
    Explor Target Antitumor Ther; 2023; 4(4):657-668. PubMed ID: 37745691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
    Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
    Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.
    Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X
    Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
    Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
    Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
    Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
    Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisequence MRI-based radiomics nomogram for early prediction of osimertinib resistance in patients with non-small cell lung cancer brain metastases.
    Lv X; Li Y; Xu X; Zheng Z; Li F; Fang K; Wang Y; Wang B; Hou D
    Eur J Radiol Open; 2023 Dec; 11():100521. PubMed ID: 37692549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
    Balasubramanian SK; Sharma M; Venur VA; Schmitt P; Kotecha R; Chao ST; Suh JH; Angelov L; Mohammadi AM; Vogelbaum MA; Barnett GH; Jia X; Pennell NA; Ahluwalia MS
    Neuro Oncol; 2020 Feb; 22(2):267-277. PubMed ID: 31648302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.